NPPB and amyloidosis: These potential confounders are particularly relevant in relation to the specificity of NT-proBNP and hs-cTnT cutoffs as they could lead to some TTRv carriers or ATTRv amyloidosis patients being wrongly selected for additional testing for cardiac involvement.